Commission Implementing Regulation (EU) No 1359/2014 of 18 December 2014 amending the Annex to Regulation (EU) No 37/2010, as regards the substance tulathromycin Text with EEA relevance

• CELEX: Implementing Regulation (EU) No 1359/2014
• Articles: 3

Article 1

The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

It shall apply from 17 February 2015.

Schedules & Appendices

ANNEX

ANNEX

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance tulathromycin is replaced by the following:

Pharmacologically active Substance

Marker residue

Animal Species

MRL

Target Tissues

Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)

Therapeutic classification

‘Tulathromycin

(2R,3S,4R,5R,8R,10R,11R,12S, 13S,14R)-2-ethyl-3,4,10,13-tetra-hydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethy-lamino)-ß-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopent-decan-15-one expressed as tulathromycin equivalents

Bovine

300 μg/kg

200 μg/kg

4 500 μg/kg

3 000 μg/kg

Muscle

Fat

Liver

Kidney

Not for use in animals from which milk is produced for human consumption

Provisional MRLs expire on 1 January 2015

Anti-infectious agents/Antibiotics’

Porcine

800 μg/kg

300 μg/kg

4 000 μg/kg

8 000 μg/kg

Muscle

Skin and fat in natural proportions

Liver

Kidney

Provisional MRLs expire on 1 January 2015